TipRanks
Go Ultimate55% OFF

SynAct Pharma AB (SYNACT) Stock Forecast & Price Target

See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

SYNACT Analyst Ratings

There are no analyst ratings in the last 3 months.

SYNACT Stock 12 Month Forecast

There are no analyst price targets in the last 3 months.

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for SE:SYNACT
Price TargetFollowArticle
TipRanks - PerPlexitySEK 17→SEK 16.50hold1.73%UpsideReiterated11/01/26
TipRanks - GoogleSEK 17.50→SEK 17hold4.81%UpsideReiterated11/01/26
TipRanks - AnthropicSEK 16.50→SEK 16hold-1.36%DownsideUpgraded11/01/26
TipRanks - OpenAISEK 16.50→SEK 16hold-1.36%DownsideReiterated11/01/26
TipRanks - DeepSeekSEK 16.50→SEK 15.50hold-4.44%DownsideReiterated11/01/26
TipRanks - xAISEK 17→SEK 16.50hold1.73%UpsideReiterated11/01/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ORKAOruka Therapeutics
ACHVAchieve Life Sciences
OVIDOvid Therapeutics
ZYMEZymeworks
CELCCelcuity

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

SYNACT Analyst Recommendation Trends

00.511.52Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
Monthly rating counts for SYNACT
RatingJun 26Jul 26Aug 26Sep 26Oct 26
Strong Buy00000
Buy00000
Hold00000
Sell00000
Strong Sell00000
total00000

In the current month, SYNACT has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. SYNACT average Analyst price target in the past 3 months is ―.

SYNACT Financial Forecast

SEK -2SEK -1.5SEK -1SEK -0.5SEK 0Q4 2025Q2 2026Q3 2026
ConsensusSEK -0.39

SYNACT Earnings Forecast

Next quarter’s earnings estimate for SYNACT is -SEK 0.39 with a range of ― to ―. The previous quarter’s EPS was -SEK 0.39. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

SEK -1SEK -0.5SEK 0SEK 0.5SEK 1Q4 2025Q2 2026Q3 2026
ConsensusSEK 0.00

SYNACT Sales Forecast

Next quarter’s sales forecast for SYNACT is SEK 0 with a range of ― to ―. The previous quarter’s sales results were SEK 0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

SYNACT Stock Forecast FAQ

Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
What do analysts say about SynAct Pharma AB?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of SynAct Pharma AB?
To buy shares of SE:SYNACT, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.